IL160742A0 - 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines - Google Patents

6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines

Info

Publication number
IL160742A0
IL160742A0 IL16074202A IL16074202A IL160742A0 IL 160742 A0 IL160742 A0 IL 160742A0 IL 16074202 A IL16074202 A IL 16074202A IL 16074202 A IL16074202 A IL 16074202A IL 160742 A0 IL160742 A0 IL 160742A0
Authority
IL
Israel
Prior art keywords
pyrazolo
pyrazol
dihydro
ones
inflammatory cytokines
Prior art date
Application number
IL16074202A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL160742A0 publication Critical patent/IL160742A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL16074202A 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines IL160742A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20
PCT/US2002/030135 WO2003024971A1 (en) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Publications (1)

Publication Number Publication Date
IL160742A0 true IL160742A0 (en) 2004-08-31

Family

ID=23259997

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16074102A IL160741A0 (en) 2001-09-20 2002-09-20 Compounds which inhibit the release of inflammatory cytokines
IL16068202A IL160682A0 (en) 2001-09-20 2002-09-20 Spirocyclic-6, 7-dihydro-5h-pyrazolo [1,2a] pyrazol-1-ones which control inflammatory cytokines
IL16074202A IL160742A0 (en) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL16074102A IL160741A0 (en) 2001-09-20 2002-09-20 Compounds which inhibit the release of inflammatory cytokines
IL16068202A IL160682A0 (en) 2001-09-20 2002-09-20 Spirocyclic-6, 7-dihydro-5h-pyrazolo [1,2a] pyrazol-1-ones which control inflammatory cytokines

Country Status (33)

Country Link
US (2) US6566357B1 (xx)
EP (3) EP1427728B1 (xx)
JP (3) JP2005504082A (xx)
KR (4) KR100623879B1 (xx)
CN (3) CN1250551C (xx)
AR (3) AR037237A1 (xx)
AT (3) ATE356126T1 (xx)
AU (2) AU2002334641B2 (xx)
BR (3) BR0212905A (xx)
CA (3) CA2461073A1 (xx)
CO (3) CO5560590A2 (xx)
CY (1) CY1106398T1 (xx)
CZ (3) CZ2004361A3 (xx)
DE (3) DE60202782T2 (xx)
DK (2) DK1427732T3 (xx)
EG (2) EG24413A (xx)
ES (3) ES2282459T3 (xx)
HK (2) HK1071366A1 (xx)
HU (3) HUP0402378A3 (xx)
IL (3) IL160741A0 (xx)
MA (3) MA27066A1 (xx)
MX (3) MXPA04002569A (xx)
MY (2) MY129329A (xx)
NO (2) NO20041594L (xx)
NZ (3) NZ531123A (xx)
PE (3) PE20030474A1 (xx)
PL (3) PL370362A1 (xx)
PT (3) PT1427727E (xx)
RU (3) RU2272040C2 (xx)
SA (1) SA03230529B1 (xx)
SK (3) SK1502004A3 (xx)
WO (3) WO2003024973A1 (xx)
ZA (3) ZA200401260B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
CA2497007A1 (en) * 2002-09-09 2004-03-18 Amgen Inc. 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives s tnf-alpha and interleukin lowering agents for the treatment of inflammations
ATE361296T1 (de) * 2003-04-03 2007-05-15 Merck Patent Gmbh Pyrazolidin-1,2-dicarbonsäure-1-((phenyl)-amid) 2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
AU2007238071B2 (en) * 2006-04-18 2012-06-07 Abbvie Inc. Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
DK2432767T3 (da) * 2009-05-19 2013-09-30 Dow Agrosciences Llc Forbindelser og fremgangsmåder til at kontrollere svampe
EP3308059B1 (en) 2015-06-15 2021-05-26 Cummins, Inc. Combustion chamber elasticity device
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
EP4422621A1 (en) * 2021-10-27 2024-09-04 Merck Sharp & Dohme LLC Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (xx) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
PT1481970E (pt) * 1999-09-07 2006-07-31 Syngenta Participations Ag Novos herbicidas
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
EG24363A (en) 2009-03-04
EG24413A (en) 2009-05-25
MY129329A (en) 2007-03-30
CY1106398T1 (el) 2011-10-12
CZ2004345A3 (cs) 2004-06-16
ZA200401403B (en) 2004-08-30
RU2004111803A (ru) 2005-10-10
EP1427727A1 (en) 2004-06-16
DE60202782D1 (de) 2005-03-03
AR037145A1 (es) 2004-10-27
EP1427732A1 (en) 2004-06-16
HK1071366A1 (en) 2005-07-15
BR0212716A (pt) 2004-08-03
CO5560589A2 (es) 2005-09-30
US20030105084A1 (en) 2003-06-05
RU2299885C2 (ru) 2007-05-27
DE60218704T2 (de) 2007-11-08
MA27066A1 (fr) 2004-12-20
KR20040035837A (ko) 2004-04-29
RU2272040C2 (ru) 2006-03-20
SA03230529B1 (ar) 2008-06-21
CA2461072A1 (en) 2003-03-27
MXPA04002570A (es) 2004-05-31
BR0212905A (pt) 2004-10-13
US6821971B2 (en) 2004-11-23
PT1427727E (pt) 2005-06-30
AU2002327690B2 (en) 2006-07-20
KR100623879B1 (ko) 2006-09-19
SK1502004A3 (en) 2004-09-08
NZ531122A (en) 2005-09-30
AU2002334641B2 (en) 2007-03-29
CZ2004361A3 (cs) 2004-07-14
AR037237A1 (es) 2004-11-03
ES2268154T3 (es) 2007-03-16
RU2004111806A (ru) 2005-03-27
ZA200401260B (en) 2004-08-30
MA27064A1 (fr) 2004-12-20
SK1492004A3 (en) 2004-11-03
DK1427728T3 (da) 2007-07-09
KR20040035835A (ko) 2004-04-29
NZ531123A (en) 2006-08-31
KR20060036125A (ko) 2006-04-27
PE20030446A1 (es) 2003-07-21
HUP0500752A2 (en) 2006-01-30
DE60202782T2 (de) 2006-01-19
PL370415A1 (en) 2005-05-30
ZA200401402B (en) 2004-08-27
KR100656126B1 (ko) 2006-12-12
JP2005504083A (ja) 2005-02-10
CN1249066C (zh) 2006-04-05
ATE356126T1 (de) 2007-03-15
EP1427732B1 (en) 2006-07-12
KR20040035836A (ko) 2004-04-29
ES2237691T3 (es) 2005-08-01
AR037502A1 (es) 2004-11-17
CO5560590A2 (es) 2005-09-30
HUP0402378A2 (hu) 2005-02-28
EP1427727B1 (en) 2005-01-26
HK1071565A1 (en) 2005-07-22
BR0212673A (pt) 2004-08-24
WO2003024970A1 (en) 2003-03-27
CA2461071A1 (en) 2003-03-27
JP2005504081A (ja) 2005-02-10
PE20030474A1 (es) 2003-07-22
US6566357B1 (en) 2003-05-20
CN1257905C (zh) 2006-05-31
DE60218704D1 (de) 2007-04-19
ES2282459T3 (es) 2007-10-16
CN1250551C (zh) 2006-04-12
SK1482004A3 (en) 2004-08-03
CA2461073A1 (en) 2003-03-27
RU2278864C2 (ru) 2006-06-27
WO2003024971A1 (en) 2003-03-27
PT1427732E (pt) 2006-12-29
IL160741A0 (en) 2004-08-31
NO20041605L (no) 2004-06-21
PT1427728E (pt) 2007-05-31
JP2005504082A (ja) 2005-02-10
MY129069A (en) 2007-03-30
WO2003024973A1 (en) 2003-03-27
HUP0402500A2 (hu) 2005-03-29
RU2004111805A (ru) 2005-04-10
CN1555375A (zh) 2004-12-15
IL160682A0 (en) 2004-08-31
MA27065A1 (fr) 2004-12-20
DE60213108T2 (de) 2007-02-08
HUP0402378A3 (en) 2008-10-28
CN1556811A (zh) 2004-12-22
HUP0402500A3 (en) 2008-10-28
MXPA04002569A (es) 2004-05-31
DK1427732T3 (da) 2006-10-30
CO5560579A2 (es) 2005-09-30
PL370351A1 (en) 2005-05-16
PL370362A1 (en) 2005-05-16
CN1555379A (zh) 2004-12-15
ATE332901T1 (de) 2006-08-15
MXPA04002574A (es) 2004-06-18
ATE287887T1 (de) 2005-02-15
PE20030430A1 (es) 2003-06-24
EP1427728A1 (en) 2004-06-16
NO20041594L (no) 2004-06-21
EP1427728B1 (en) 2007-03-07
CZ2004358A3 (cs) 2004-07-14
DE60213108D1 (de) 2006-08-24
NZ531063A (en) 2007-08-31

Similar Documents

Publication Publication Date Title
GB2383567B (en) Vehicle stability control
ZA200309648B (en) Azaindoles.
IL160742A0 (en) 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines
GB0102212D0 (en) Controller
AU2003255323A1 (en) Imidazo`1,2-a!pyridines
AU2002233706A1 (en) Pyridopyrimidine or naphthyridine derivative
MXPA03007623A (es) Derivado de piridopirimidina o naftiridina.
EP1380924A4 (en) CONTROL
AUPR528001A0 (en) Firearms
GB0106099D0 (en) Carriages
AU2002343106A1 (en) Contactors
AU2002329267A1 (en) Antibacterial macrocycles
EP1439303A4 (en) AUTOMATIC CONTROL UNIT CONTROL UNIT
AUPR757501A0 (en) Firearms
AU2002318478A1 (en) Zeolite ssz-59
GB2374730B (en) Control
AU2002233664A1 (en) Naphthyridine derivative
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
GB0223095D0 (en) Contactors
AU2002244935A1 (en) 8-thiazolyl(1,2,4)triazolo(1,5-c)pyrimidine derivative
GB0112658D0 (en) Control structure
AU2002246225A1 (en) Movable structure
AU2002241155A1 (en) Control arrangement
AUPR864601A0 (en) Geomatrix
AUPR513501A0 (en) Controller